Patient-Specific Access For Locally Unlicenced Therapies

When a therapy is approved somewhere in the world but not marketed locally, treatment plans face a gap. Individual Import closes that gap by converting external approvals into named-patient access.

Individual Import is the bridge between global innovation and local care. In settings where suitable local options are absent, approved therapies from other regions become additional choices for individual patients.

When a medicine exists but isn’t available locally, Individual Import enables compliant, patient-specific access so treatment can proceed without waiting for commercialization.

About Individual Import

A true extension of therapeutic choice, Individual import creates another chance for the patient.

  • Access to global innovation

    Case-by-case access to therapies approved in other regions when local options are absent or unsuitable.
  • Clinically governed, patient-first

    Access grounded in medical need and aligned with hospital committees for transparent, defensible decisions.
  • Transparent cost & procurement fit

    Upfront quotes compatible with hospital purchasing and budget workflows.
  • Supply Optimization

    Optimization for accelerated lead time on routinely imported products.

Our Named Patient Import Services

Why Komtur?

  • Patient-First, Care-Centric Handling

    Single case owner, transparent status, and checklist documentation help keep cases moving and care continuous.

  • Speed with Certainty

    Bonded-warehouse release, established customs and Importer of Record (IOR) workflows, and temperature-controlled last-mile delivery to hospital or pharmacy receipt.

  • Licensed Global Access Network

    Quality-assured sourcing with falsified-medicines safeguards, serialization, and end-to-end batch traceability.

  • Authority-Aligned, Multi-Country Enablement

    Correct use of named-patient and shortage pathways, plus practical broker and IOR guidance as well as documentation support.

  • Proactive Access Insights

    Continuous shortage and regulatory-approval monitoring, demand validation, and early qualification of alternatives to protect continuity of care.

“We understand that behind every order is a patient in need, and have built our process to deliver on that.”